Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11746103 ALK-5 inhibitors and uses thereof

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
April 29, 2022
Date of Patent
September 5, 2023
Patent Application Number
17733650
Patent Citations
‌
US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
‌
US Patent 8552156 Anti-TIM-3 antibody
‌
US Patent 8686119 Variants of humanized immunomodulatory monoclonal antibodies
‌
US Patent 8735553 Anti-PD1 antibodies and their use as therapeutics and diagnostics
‌
US Patent 8779108 Targeted binding agents against B7-H1
‌
US Patent 8841418 Antibodies that specifically bind to TIM3
‌
US Patent 8907053 Immunosuppression modulating compounds
‌
US Patent 8927697 PD-1 specific antibodies and uses thereof
‌
US Patent 8993731 PD-1 antibody
‌
US Patent 9102727 Human anti-PD-1 antibodies and uses therefor
•••
Patent Inventor Names
Steven L. Warner
Srinivas Padakanti
Adam Siddiqui-Jain
Naresh Kumar
Siva Reddy Basireddy
Bettina Franz
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11746103
Patent Primary Examiner
‌
Brian E McDowell
CPC Code
‌
C07D 413/14
‌
C07D 405/14
‌
C07D 403/14
‌
C07D 403/12
‌
C07D 401/14

Find more entities like US Patent 11746103 ALK-5 inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo